Celebrity Inventors
Magician Harry Houdini patented a "Diver's Suit" enabling the wearer to "quickly divest himself of the suit while being submerged and to safely escape and reach the surface of the water."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8182833 | Method and kit for reducing the symptoms of peripheral vascular disease with topical progesterone A method for reducing the symptoms of peripheral vascular disease and for improving peripheral circulation wherein a progestin is administered to a subject in need thereof. ... | 05/22/2012 |
| 8143227 | Azithromycin for treatment of skin disorders Azithromycin has increased efficacy in treating acne and other skin conditions when administered systemically at low doses, below those previously known to produce a clinical antibiotic effect. ... | 03/27/2012 |
| 8124123 | Controlled release azithromycin solid dosages forms A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form. ... | 02/28/2012 |
| 8039494 | Compositions and methods for treating diseases of the nail Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutical... | 10/18/2011 |
| 7893097 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid. ... | 02/22/2011 |
| 7829523 | Method for stabilizing polypeptides lacking methionine Methionine is an effective antioxidant for polypeptides having an amino acid sequence lacking methionine. Compositions containing polypeptides having an amino acid sequence that is free of methionine residues are stabilized from oxidative degradation by combining me... | 11/09/2010 |
| 7794939 | Methods of DNA methylation detection The present invention provides for methods of DNA methylation detection. The present invention provides for methods of generating and detecting specific electronic signals that report the methylation status of targeted DNA molecules in biological samples. Two... | 09/14/2010 |
| 7740864 | Vaccines for diseases of fish Fish are immunized by a mass vaccination method, such as by immersion in water containing an attenuated strain of a pathogenic bacterium that does not effectively cause disease in fish when the non-attenuated pathogenic bacterium is exposed to the fish by immersion.... | 06/22/2010 |
| 7713715 | Method for diagnosing infections Antigens are removed from the surface of an organism, such as a microorganism, without disrupting the organism and releasing internal antigens of the organism. The free surface antigens of the organism may be used to determine the presence of infection in an animal ... | 05/11/2010 |
| 7705197 | Embryo development and survival An embryo that is transferred into the uterus of a recipient female is protected from embryotoxic effects of prostaglandin F2α by exposing the embryo to a prostaglandin antagonist. ... | 04/27/2010 |
| 7674783 | Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the... | 03/09/2010 |
| 7629116 | Type I interferon-inducible proteins to detect viral infection A method for determining the presence of a viral infection in an animal not known to have been infected with a virus or other disease-causing microbial organism by determining the level of Mx protein or other Type I Interferon-inducible protein in the animal. ... | 12/08/2009 |
| 7572780 | Method and kit for reducing the symptoms of peripheral vascular disease A method for reducing the symptoms of peripheral vascular disease wherein a chemical agent that reduces peripheral vascular hyperreactivity in response to a stimulus for contraction of peripheral vascular musculature is administered to a subject in need thereof. Kit... | 08/11/2009 |
| 7560120 | Vehicles for delivery of biologically active substances A formulation containing one or more biologically active substances dissolved, dispersed, emulsified, or suspended within a vehicle of one or more citric acid esters and/or citric acid ethers. Methods for making and using are disclosed, as are kits for administratio... | 07/14/2009 |
| 7524511 | Method and kit for moisturizing the surface of the eye A method for moisturizing the eye in which an amount of aqueous fluid is administered to the eye in an amount below that which causes flooding of the eye and removal of the normal tear film from the surface of the eye. The fluid, when administered in accordance with... | 04/28/2009 |
| 7517955 | adhesion molecule A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be... | 04/14/2009 |
| 7422869 | Method for diagnosing infectious diseases A method for diagnosing the presence in an animal of an infection due to a microorganism in which a test sample obtained from the animal is exposed to a population of the microorganism and the presence of binding of the microorganism by an antibody in the test sampl... | 09/09/2008 |
| 7368122 | Skin cream An emulsion for topical application to the skin containing a high molecular weight emulsifier and substantially no emulsifiers of a molecular weight less than 100 kD. The emulsion may be used to prevent or treat dermatoses and may additionally contain pharmaceutical... | 05/06/2008 |
| 7348317 | Aqueous compositions containing metronidazole An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is niacin or niacinamid... | 03/25/2008 |
| 7326408 | Topical acne vulgaris medication with a sunscreen Increased compliance in the use of topical sunscreens is obtained by combining a topical sunscreen agent in a formulation containing an antibacterial medication such as azelaic acid or an antibiotic. ... | 02/05/2008 |
| 7323620 | Activation of equine oocytes A method for activating an equine oocyte comprising exposing oocyte to a medium containing a concentration of calcium of at least about 4 mM. Preferably the oocyte is exposed to this concentration of calcium during activation. ... | 01/29/2008 |
| 7276350 | Method for diagnosing infectious diseases A method for diagnosing the presence in an animal of an infection due to a microorganism in which a test sample obtained from the animal is exposed to a population of the microorganism and the presence of binding of the microorganism by an antibody in the test sampl... | 10/02/2007 |
| 7252816 | Topical acne vulgairs medication with a sunscreen Increased compliance in the use of topical sunscreens is obtained by combining a topical sunscreen agent in a formulation containing an antibacterial medication such as azelaic acid or an antibiotic. ... | 08/07/2007 |
| 7160696 | Bovine lymphocyte-derived antibacterial protein A nucleic acid sequence encoding a polypeptide having antibacterial activity, which nucleic acid sequence has the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13 or is a nucleic acid that hybridizes under highly stringent conditions to a complement of a nu... | 01/09/2007 |
| 7125728 | Determination of pregnancy status in cattle and sheep A method and kit for determining whether an animal is not pregnant, or is pregnant following a breeding. The level of expression of a pregnancy induced protein is determined in an animal for which pregnancy status information is desired and the level is compared to ... | 10/24/2006 |
| 7067321 | Polyglutamine repeat sequences Several neurodegenerative diseases result from the aggregation of polyglutamine repeat proteins into insoluble neuronal intranuclear inclusions. The invention provides methods with which to study the processes of these diseases, including methods for solubilizing po... | 06/27/2006 |
| 7041859 | Method for halogenating or radiohalogenating a chemical compound A method for obtaining a halogenated organic compound, whereby an organotrifluoroborate compound is reacted with a halide ion in the presence of an oxidizing agent to produce the corresponding halogenated organic compound. The method may be used for producing radioh... | 05/09/2006 |
| 6960346 | Vehicles for delivery of biologically active substances A formulation containing one or more biologically active substances dissolved, dispersed, emulsified, or suspended within a vehicle of one or more citric acid esters and/or citric acid ethers. Methods for making and using are disclosed, as are kits for administratio... | 11/01/2005 |
| 6936637 | Prevention of apoptosis in non-cancerous cells Treatment of normal, non-cancerous, animal cells with an agent that depletes polyamines within the cells results in an inhibition of apoptosis when the cells are exposed to an inducer of apoptosis. This inhibition of apoptosis is not observed, or is observed to a le... | 08/30/2005 |
| 6916852 | Method for regulation of microvascular tone Methods and kits for regulating arterial microvascular tone in which a COX-2 inhibitor and a cannabinoid receptor agonist are co-administered to a subject. ... | 07/12/2005 |
| 6881726 | Aqueous compositions containing metronidazole An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is a compound other tha... | 04/19/2005 |
| 6645715 | Artificial cornea The invention provides an in vitro avascular human corneal equivalent that comprises immortalized human cell lines. As these corneal equivalents are in vitro models, they are maintained in an incubator throughout the testing period, thereby eliminating th... | 11/11/2003 |
| 6602487 | Methods and tests for producing and for inhibiting coronary artery vasospasms Methods for producing coronary vasospasms and for inhibiting coronary vasospasms are disclosed. Both in vivo and in vitro methods are disclosed. The methods are useful as tests for determining the ability of a chemical compound to inhibit or reduce corona... | 08/05/2003 |
| 6593457 | Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein A purified, soluble lymphocyte-derived antimicrobial protein that has a molecular weight of 16 kD on SDS-PAGE, is inactivated by heating at 56° C. for 30 minutes or by treatment with trypsin, is expressed by CD3-, CD2+ cytokine-stimulated cells', and is ... | 07/15/2003 |
| 6589922 | Skin cleanser comprising a steareth, poloxamer, and a glyceryl monoester A non-irritating skin cleanser that contains water, a non-ionic surfactant, and a glyceryl monoester of a fatty acid. The skin cleanser is especially useful for cleansing irritated, diseased, damaged, or sensitive skin. The cleanser is especially useful f... | 07/08/2003 |
| 6511969 | Method for reducing coronary artery reactivity A method for reducing coronary artery reactivity. A predetermined amount of natural progesterone is provided by a convenient and pleasant delivery system to the blood stream, sufficient to reduce the likelihood of coronary vasospasm and myocardial ischemi... | 01/28/2003 |
| 6498192 | Prevention of apoptosis in non-cancerous cells Treatment of normal, non-cancerous, animal cells with an agent that depletes polyamines within the cells results in an inhibition of apoptosis when the cells are exposed to an inducer of apoptosis. This inhibition of apoptosis is not observed, or is obser... | 12/24/2002 |
| 6423315 | Synthetic peptide for treatment of autoimmune arthritis Peptides that are capable of suppressing autoimmune arthritis are disclosed. The polypeptides described by the present invention which are capable of suppressing autoimmune arthritis in mammals include analogues of CII 245-270. The peptides do not provoke... | 07/23/2002 |
| 6357394 | Cage for housing dangerous animals A cage for housing animals, particularly for dangerous animals like venomous snakes, is disclosed. The cage has at least two compartments, one of which is an externally sealable drawer that can be removed from the cage by sliding it from the other compone... | 03/19/2002 |
| 6108818 | Skin adherent sweat band A novel sweat band absorbs perspiration on the forehead, permits unrestricted air flow to portions of the head other than the forehead, and does not dishevel the wearer's hair. The sweat band secures to a person's head in a manner other than encircling th... | 08/29/2000 |
